摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1H-吡咯-1-乙酸 | 19167-98-7

中文名称
1H-吡咯-1-乙酸
中文别名
——
英文名称
2-(1H-pyrrol-1-yl)acetic acid
英文别名
1-pyrrolylacetic acid;pyrrol-1-yl-acetic acid;2-(pyrrol-1-yl)acetic acid;1h-Pyrrole-1-acetic acid;2-pyrrol-1-ylacetic acid
1H-吡咯-1-乙酸化学式
CAS
19167-98-7
化学式
C6H7NO2
mdl
MFCD00955795
分子量
125.127
InChiKey
CHRZYRWWZQCZBV-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    91.5 °C
  • 沸点:
    271.4±23.0 °C(Predicted)
  • 密度:
    1.18±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.7
  • 重原子数:
    9
  • 可旋转键数:
    2
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    42.2
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 危险等级:
    IRRITANT
  • 海关编码:
    2933990090
  • 危险性防范说明:
    P280,P305+P351+P338
  • 危险性描述:
    H317,H319
  • 储存条件:
    2-8°C,干燥

SDS

SDS:4b65041cbe831bc89c47a129cb2700b3
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1H-Pyrrol-1-ylacetic acid
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1H-Pyrrol-1-ylacetic acid
CAS number: 19167-98-7

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C6H7NO2
Molecular weight: 125.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    高功能化四氢吲哚嗪衍生物的串联顺序催化对映选择性合成
    摘要:
    通过一锅串联顺序过程报道了新型四氢吲哚嗪衍生物的异硫脲催化的对映选择性合成。在对映选择性迈克尔加成-内酯化过程中,将2-(吡咯-1-基)乙酸与三氟甲基烯酮或α-酮-β,γ-不饱和酯结合使用,然后进行原位开环和环化,导致一系列24种四氢吲哚嗪衍生物包含三个立体中心,其最大> 95:5 dr和> 99:1 er。
    DOI:
    10.1039/d0sc00432d
  • 作为产物:
    描述:
    methyl 2-(1-pyrrolyl)acetate 、 lithium hydroxide 作用下, 以 甲醇 为溶剂, 以44 %的产率得到1H-吡咯-1-乙酸
    参考文献:
    名称:
    N-取代乙酸对醛的光催化脱羧加成
    摘要:
    在此,我们报道了在温和的反应条件下,光氧化还原催化的 N-取代乙酸脱羧加成醛生成仲醇。发现质子溶剂对该方法的成功实施至关重要。该策略能够在醛和弱亲核性和医学相关杂芳基(如吲哚、吡咯、吲唑和氮杂吲哚)的 N-取代乙酸衍生物之间形成新的 C-C 键。
    DOI:
    10.1021/acs.joc.2c01843
点击查看最新优质反应信息

文献信息

  • Cyclic hydrocarbons with an aminoalkyl sidechain
    申请人:The Upjohn Company
    公开号:US04917826A1
    公开(公告)日:1990-04-17
    Provided are cyclic hydrocarbons of Formula I ##STR1## with an aminoalkyl sidechain that are useful for treating phospholipase A2 mediated conditions, diabetes, and obesity.
    提供的是具有氨基烷基侧链的化学式I的环烃,可用于治疗磷脂酶A2介导的疾病、糖尿病和肥胖症。
  • Photoassisted Synthesis of Enantiopure Alkaloid Mimics Possessing Unprecedented Polyheterocyclic Cores
    作者:N.N. Bhuvan Kumar、Olga A. Mukhina、Andrei G. Kutateladze
    DOI:10.1021/ja4042109
    日期:2013.7.3
    high yielding intramolecular cycloadditions of photogenerated azaxylylenes tethered to pyrroles, with further growth of molecular complexity via post-photochemical transformations of primary photoproducts. This expeditious access to structurally unprecedented polyheterocyclic cores is being developed in the context of diversity-oriented synthesis, as the modular design allows for rapid "pre-assembly"
    对映纯生物碱模拟物是通过光生氮杂二甲苯与吡咯的高产分子内环加成反应合成的,并通过初级光产物的光化学后转化进一步增加分子复杂性。这种对结构上前所未有的多杂环核的快速访问是在面向多样性的合成背景下开发的,因为模块化设计允许从简单的构建块/多样性输入快速“预组装”各种光前体。
  • Photoredox Catalysis: 1,4-Conjugate Addition of <i>N</i>-Methyl Radicals to Electron-Deficient Olefins via Decarboxylation of <i>N</i>-Substituted Acetic Acids
    作者:Lakshmaiah Gingipalli、Jeffrey Boerth、David Emmons、Tyler Grebe、Holia Hatoum-Mokdad、Bo Peng、Li Sha、Sharon Tentarelli、Haixia Wang、Ye Wu、XiaoLan Zheng、Scott Edmondson、Ariamala Gopalsamy
    DOI:10.1021/acs.orglett.0c00873
    日期:2020.5.1
    In this report, we describe a new photoredox catalyzed 1,4-conjugate addition of N-substituted acetic acids to electron-deficient olefins via decarboxylative C-C bond formation. This C-C bond formation occurred under mild conditions enabled by visible light irradiation. This transformation facilitated the synthesis of biologically relevant N-substituted heterocyclic structural motifs not readily accessible
    在本报告中,我们描述了一种新的光氧化还原催化 1,4-共轭加成 N-取代的乙酸通过脱羧 CC 键形成缺电子烯烃。这种CC键形成发生在可见光照射的温和条件下。这种转化促进了其他方法不易获得的生物学相关的 N 取代杂环结构基序的合成。CC键形成方案应用于弱亲核杂环,如吲哚、吲唑、咪唑和环状酰胺,以形成功能化的药物样小分子。
  • [EN] LIVER X RECEPTOR (LXR) MODULATORS FOR THE TREATMENT OF DERMAL DISEASES, DISORDERS AND CONDITIONS<br/>[FR] MODULATEURS DU RÉCEPTEUR HÉPATIQUE X (LXR) PERMETTANT DE TRAITER LES MALADIES, TROUBLES ET AFFECTIONS DERMIQUES
    申请人:ANAYADERM INC
    公开号:WO2013130892A1
    公开(公告)日:2013-09-06
    Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of dermal diseases, disorders or conditions. Also described herein are pharmaceutical compositions containg such compounds.
    本文描述了肝X受体(LXR)调节剂以及在治疗皮肤疾病、紊乱或状况中利用LXR调节剂的方法。本文还描述了含有这些化合物的药物组合物。
  • Isothiourea-Catalyzed Enantioselective Functionalization of 2-Pyrrolyl Acetic Acid: Two-Step Synthesis of Stereodefined Dihydroindolizinones
    作者:Shuyue Zhang、James E. Taylor、Alexandra M. Z. Slawin、Andrew D. Smith
    DOI:10.1021/acs.orglett.8b02423
    日期:2018.9.7
    Catalytic enantioselective functionalization of 2-pyrrolyl acetic acid with trichloromethyl enones using isothiourea catalysis is reported, leading to a range of stereodefined diesters and diamides after nucleophilic ring opening with either methanol or benzylamine (30 examples, up to >95:5 dr and >99:1 er). Subsequent intramolecular Friedel–Crafts reaction allows access to dihydroindolizinones in high yields
    据报道,使用异硫脲催化三氯甲基烯酮对2-吡咯基乙酸的催化对映选择性官能化,导致在用甲醇或苄基胺亲核开环后产生一系列立体定义的二酯和二酰胺(30个实例,高达> 95:5 dr和> 99 :1 er)。随后的分子内Friedel-Crafts反应可实现高收率和立体保真度的二氢吲哚并酮(6个实例,高达> 95:5 dr和99:1 er)。
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 齐特巴坦 齐德巴坦钠盐 齐墩果-12-烯-28-酸,2,3-二羟基-,苯基甲基酯,(2a,3a)- 齐墩果-12-烯-28-酸,2,3-二羟基-,羧基甲基酯,(2a,3b)-(9CI) 黄酮-8-乙酸二甲氨基乙基酯 黄荧菌素 黄体生成激素释放激素 (1-5) 酰肼 黄体瑞林 麦醇溶蛋白 麦角硫因 麦芽聚糖六乙酸酯 麦根酸 麦撒奎 鹅膏氨酸 鹅膏氨酸 鸦胆子酸A甲酯 鸦胆子酸A 鸟氨酸缩合物